Use of a beta-agonist in ventilated, very-low-birth-weight babies: a longitudinal evaluation

Dev Pharmacol Ther. 1990;15(2):61-7. doi: 10.1159/000457623.

Abstract

To determine if there is a specific postnatal (PNA) or postconceptional age (PCA) at which ventilated preterm infants respond to beta-agonists, we evaluated 15 infants with a mean gestational age of 26.5 +/- 1.5 weeks and mean birth weight of 0.89 +/- 0.23 kg who required mechanical ventilation at 10 days of age. Weekly pulmonary function testing (PFT) was performed before and 1 h after administration of albuterol. Taking the group as a whole, as well as individual babies, regression analysis showed no relationship between positive response and either PNA or PCA. Evaluation of individual infants, however, showed that some consistently responded to beta-agonists whereas others did not. We recommend individual PFT to identify those infants who will benefit from use of beta-agonists.

MeSH terms

  • Albuterol / therapeutic use*
  • Blood Pressure / drug effects
  • Gestational Age
  • Heart Rate / drug effects
  • Humans
  • Infant, Low Birth Weight*
  • Infant, Newborn
  • Longitudinal Studies
  • Respiration, Artificial
  • Respiratory Distress Syndrome, Newborn / drug therapy*
  • Tidal Volume / drug effects

Substances

  • Albuterol